| Serial Number | 79204968 |
| Word Mark | VECTURA V |
| Filing Date | Thursday, November 3, 2016 |
| Status | 709 - CANCELLED - SECTION 71 |
| Status Date | Friday, August 30, 2024 |
| Registration Number | 5398606 |
| Registration Date | Tuesday, February 13, 2018 |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, November 28, 2017 |
| Description of Mark | The mark consists of the letter "V" made up of 6 oblique lines and a small triangle appearing next to the stylized word "VECTURA". |
| Goods and Services | Pharmaceutical and biological preparations for medical purposes, namely for the treatment of diseases or conditions of the respiratory system; pharmaceutical and biological preparations for medical purposes, namely the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynaecological conditions; pharmaceutical and biological preparations for medical purposes, namely for the alleviation or prevention of pain or inflammation; pharmaceutical and biological preparations for medical purposes, namely, powders for asthma inhalers; pharmaceutical and biological preparations for medical purposes, namely, powders for transdermal injection for the alleviation or prevention of pain, for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynecological conditions; pharmaceutical and biological preparations for medical purposes, namely for oral ingestion for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genitourinary system, infections, skin disorders and gynecological conditions; pharmaceutical and biological preparations for medical purposes, namely for topical administration for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynecological conditions; pharmaceutical and biological preparations for medical purpose, namely, medicaments for inhalation therapy; pharmaceutical and biological preparations for medical purposes, namely, pulmonary delivery compositions for use in facilitating the inhalation of pharmaceuticals, namely, drug delivery agents consisting of compounds that facilitate delivery by inhalation of a wide range of pharmaceuticals; pharmaceutical and biological preparations for medical purpose, namely medicaments for the treatment of erectile dysfunction, medicaments for the treatment of chronic obstructive pulmonary disease, medicaments for the treatment of premature ejaculation, medicaments for the treatment of cystic fibrosis, medicaments for the treatment of female sexual dysfunction, medicaments for the treatment of migraines, medicaments for the treatment of asthma |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Goods and Services | Medical apparatus and instruments, namely drug delivery devices, namely drug delivery systems; inhalers for medical use; metered dose inhalers for medical use; active dry powder inhalers for medical use; passive dry powder inhalers for medical use; nebulisers for respiration therapy; respirators for artificial respiration; parts and fittings for all the aforesaid goods |
| Goods and Services | Scientific research, development, design, analysis, testing and investigation relating to medical preparations and drug delivery devices; medical research; research relating to drug delivery devices; research relating to drug formulation; pharmaceutical development; preparation and formulation of pharmaceuticals; device and product testing |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | F - NOT AVAILABLE |
| Class Status Date | Friday, August 30, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | F - NOT AVAILABLE |
| Class Status Date | Friday, August 30, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | F - NOT AVAILABLE |
| Class Status Date | Friday, August 30, 2024 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Vectura Limited |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | GB |
| Party Name | Vectura Limited |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | GB |
| Party Name | Vectura Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | GB |
| Event Date | Event Description |
| Thursday, April 13, 2017 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, April 14, 2017 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, April 14, 2017 | ASSIGNED TO EXAMINER |
| Tuesday, April 18, 2017 | APPLICATION FILING RECEIPT MAILED |
| Wednesday, April 19, 2017 | NON-FINAL ACTION WRITTEN |
| Thursday, April 20, 2017 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Monday, April 24, 2017 | REFUSAL PROCESSED BY MPU |
| Tuesday, April 25, 2017 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Saturday, May 13, 2017 | REFUSAL PROCESSED BY IB |
| Wednesday, October 11, 2017 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, October 11, 2017 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, October 11, 2017 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, October 20, 2017 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, November 8, 2017 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, November 22, 2017 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, November 22, 2017 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Tuesday, November 28, 2017 | PUBLISHED FOR OPPOSITION |
| Tuesday, November 28, 2017 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, February 13, 2018 | REGISTERED-PRINCIPAL REGISTER |
| Sunday, May 13, 2018 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Wednesday, May 23, 2018 | FINAL DISPOSITION NOTICE SENT TO IB |
| Friday, July 13, 2018 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Saturday, October 8, 2022 | NEW REPRESENTATIVE AT IB RECEIVED |
| Monday, February 13, 2023 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |
| Friday, December 22, 2023 | NEW REPRESENTATIVE AT IB RECEIVED |
| Friday, December 8, 2017 | NOTIFICATION PROCESSED BY IB |
| Wednesday, May 23, 2018 | FINAL DISPOSITION PROCESSED |
| Friday, August 30, 2024 | CANCELLED SECTION 71 |